Ctix is a stock worth checking out. This news didnt move the SP much but in my opinion its huge. 3rd party independent corroboration made a believer out of me.
Research by BIDMC combined Kevetrin™ with sunitinib on cell line 786, a drug-resistant renal cancer. Cellceutix was advised by the researchers that "the Kevetrin/sunitinib combination is the first we've used in which actual tumor shrinkage is noted."
News 
Market Data 
Discover 
